ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Spurred by a new collaboration with Biogen Idec, the contract manufacturer PCI Synthesis has expanded its R&D and kilolab facility in Devens, Mass. The 30% capacity boost will be supported by 20 new staff members in several functional areas. PCI says it has started working with Biogen Idec’s process research group to augment the drug company’s internal small-molecule production capabilities and optimize several new compounds.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X